The Centers for Disease Control and Prevention (CDC) today released new data showing a total of 1,183,495 reports of adverse events following COVID-19 vaccines were submitted between Dec. 14, 2020, and March 11, 2022, to the Vaccine Adverse Event Reporting System (VAERS). VAERS is the primary government-funded system for reporting adverse vaccine reactions in the U.S.
The data included a total of 25,641 reports of deaths — an increase of 483 over the previous week — and 208,209 reports of serious injuries, including deaths, during the same time period — up 4,321 compared with the previous week.
Excluding “foreign reports” to VAERS, 788,624 adverse events, including 11,728 deaths and 76,231 serious injuries, were reported in the U.S. between Dec. 14, 2020, and March 11, 2022.
Foreign reports are reports foreign subsidiaries send to U.S. vaccine manufacturers. Under U.S. Food and Drug Administration (FDA) regulations, if a manufacturer is notified of a foreign case report that describes an event that is both serious and does not appear on the product’s labeling, the manufacturer is required to submit the report to VAERS.
Of the 11,728 U.S. deaths reported as of March 11, 17% occurred within 24 hours of vaccination, 22% occurred within 48 hours of vaccination and 60% occurred in people who experienced an onset of symptoms within 48 hours of being vaccinated.
In the U.S., 556 million COVID vaccine doses had been administered as of March 11, including 328 million doses of Pfizer, 209 million doses of Moderna and 19 million doses of Johnson & Johnson (J&J).
Every Friday, VAERS publishes vaccine injury reports received as of a specified date. Reports submitted to VAERS require further investigation before a causal relationship can be confirmed.
Historically, VAERS has been shown to report only 1% of actual vaccine adverse events.
U.S. VAERS data from Dec. 14, 2020, to March 11, 2022, for 5- to 11-year-olds show:
- 9,161 adverse events, including 217 rated as serious and 5 reported deaths.
The most recent death involves a 7-year-old boy (VAERS I.D. 2152560) from Washington who died 13 days after receiving his first dose of Pfizer’s COVID vaccine when he went into shock and suffered cardiac arrest. He was unable to be resuscitated and died in the emergency department.
- 17 reports of myocarditis and pericarditis (heart inflammation).
The CDC uses a narrowed case definition of “myocarditis,” which excludes cases of cardiac arrest, ischemic strokes and deaths due to heart problems that occur before one has the chance to go to the emergency department.
- 34 reports of blood clotting disorders.
U.S. VAERS data from Dec. 14, 2020, to March 11, 2022, for 12- to 17-year-olds show:
- 30,295 adverse events, including 1,744 rated as serious and 42 reported deaths.
The most recent deaths involve a 17-year-old boy (VAERS I.D. 2171083) from Illinois with Duchenne muscular dystrophy who died from cardiac arrest after receiving his second dose of Pfizer’s COVID vaccine, and 14-year-old boy from Guam (VAERS I.D. 2157944) who died one week after his first dose of Pfizer when he suddenly committed suicide.
The boy’s VAERS report states:
“Sudden suicide one week after the vaccine. Patient was a perfectly happy child. After the vaccine, he became much more tired and achy and lost interest in doing his sports. One week later, without any warning, he hung himself.”
- 68 reports of anaphylaxis among 12- to 17-year-olds where the reaction was life-threatening, required treatment or resulted in death — with 96% of cases attributed to Pfizer’s vaccine.
- 646 reports of myocarditis and pericarditis, with 634 cases attributed to Pfizer’s vaccine.
- 162 reports of blood clotting disorders, with all cases attributed to Pfizer.
U.S. VAERS data from Dec. 14, 2020, to March 11, 2022, for all age groups combined, show:
- 20% of deaths were related to cardiac disorders.
- 54% of those who died were male, 41% were female and the remaining death reports did not include the gender of the deceased.
- The average age of death was 72.7.
- As of March 11, 5,250 pregnant women reported adverse events related to COVID vaccines, including 1,668 reports of miscarriage or premature birth.
- Of the 3,613 cases of Bell’s Palsy reported, 51% were attributed to Pfizer vaccinations, 40% to Moderna and 8% to J&J.
- 863 reports of Guillain-Barré syndrome, with 41% of cases attributed to Pfizer, 30% to Moderna and 28% to J&J.
- 2,363 reports of anaphylaxis where the reaction was life-threatening, required treatment or resulted in death.
- 1,683 reports of myocardial infarction.
- 13,512 reports of blood-clotting disorders in the U.S. Of those, 6,034 reports were attributed to Pfizer, 4,818 reports to Moderna and 2,617 reports to J&J.
- 4,045 cases of myocarditis and pericarditis with 2,483 cases attributed to Pfizer, 1,377 cases to Moderna and 175 cases to J&J’s COVID vaccine.
Moderna asks FDA to authorize 4th dose for adults 18 and up
Moderna on Thursday asked the FDA to amend Emergency Use Authorization (EUA) of its COVID vaccine to include a fourth dose for adults 18 and older.
According to The Associated Press, the request is broader than Pfizer’s. Pfizer earlier this week asked the agency to authorize a fourth dose of its COVID vaccine for adults 65 and older.
In a press release, Moderna said the request to include adults over 18 was made “to provide flexibility for the U.S. Centers for Disease Control and Prevention and healthcare providers to determine the appropriate use of an additional booster dose of mRNA-1273, including for those at higher risk of COVID-19 due to age or comorbidities.”
Moderna said its decision to seek FDA approval was based on studies from the U.S. and Israel about the Omicron variant, but didn’t provide further information. Booster doses of Moderna are half the dose of the first and second doses.
Pfizer and BioNTech ask FDA to authorize fourth vaccine dose for older adults
Pfizer and BioNTech on Tuesday said they submitted a request to the FDA for EUA of an additional booster dose of their COVID vaccine for adults 65 and older.
The companies’ request was not based on robust, peer-reviewed U.S. data, but on two recent studies from Israel — both published on preprint servers without peer review.
The first study was done in conjunction with Israel’s Ministry of Health and involved a review of 1.1 million health records. The study concluded rates of COVID in those who received a fourth dose of Pfizer’s COVID vaccine were lower compared to those who received only three doses.
According to the preprint published on medRxiv, since Jan. 2 Israel has been administering a fourth dose of the Pfizer vaccine only to people over 60 and at-risk populations.
In the second study of Israeli healthcare workers, results showed a fourth dose of either Pfizer’s or Moderna’s vaccine boosted antibody levels, but neither was effective at preventing infections.
CDC deletes thousands of reported COVID-19 deaths in children
The CDC removed tens of thousands of deaths linked to COVID, including nearly a quarter of deaths it had attributed to those younger than 18, The Epoch Times reported. The change was made on March 15 on its COVID data tracker website.
“Data on deaths were adjusted after resolving a coding logic error. This resulted in decreased death counts across all demographic categories,” the CDC said on the website. The agency also acknowledged COVID death data is not complete.
Before the change, the CDC listed 1,755 deaths in children from COVID, along with 851,000 others, according to Kelley Krohnert, a Georgia resident who tracks the CDC’s updates.
The CDC removed 416 deaths among children and more than 71,000 other reported deaths — arriving at a total of about 780,000.
The CDC’s statistics are frequently cited by physicians and experts when pushing for children to receive COVID vaccines. Dr. Rochelle Walensky, the CDC’s director, referred to the tracker’s death total on November 2021 while pushing for an expert panel to advise her agency to recommend vaccination for all children 5 to 11 years old.
Vaccine researcher develops tinnitus 90 minutes after COVID shot, calls for more research
A vaccinologist at the Mayo Clinic in Minnesota said he developed tinnitus after receiving his second dose of an mRNA COVID vaccine.
Dr. Gregory Poland’s symptoms began 90 minutes after receiving the vaccine. He described the condition as “fairly severe” and “extraordinarily bothersome, interfering with sleep and the ability to concentrate.”
According to the National Institutes of Health, tinnitus is a sign that something is wrong with the auditory system. It is commonly described as a ringing in the ears, but it also can sound like roaring, clicking, hissing, or buzzing that accompanies soft, loud or high pitches.
According to the most recent VAERS data released on March 11, 19,851 people have reported developing tinnitus after a COVID vaccine, with 12,027 cases attributed to Pfizer’s COVID vaccine.
CEO of German health insurer fired after releasing data on underreported COVID vaccine injuries
The CEO of one of Germany’s largest health insurance companies was abruptly fired last month after he released data suggesting German health authorities are significantly underreporting COVID-19 vaccine injuries.
The data, released by Andreas Schofbeck of BKK/ProVita, have since been scrubbed from the company’s website.
Schofbeck, who noticed an unexpected jump in vaccine-related health insurance claims, in February notified the Paul Ehrlich Institute (PEI) — the German equivalent of the CDC — that BKK billing data indicated the PEI was underreporting adverse events to COVID vaccines.
In his letter to the PEI, Schofbeck wrote:
I’m “If these figures are extrapolated to the whole year and to the population in Germany, probably 2.5-3 million people in Germany have received medical treatment for vaccination side effects after Corona vaccination.”
Dr. Dirk Heinrich, chairman of NAV-Virchow Bund, an association of private medical practitioners in Germany, said PEI and BKK would be working closely to examine the billing code data. Heinrich also stated that the conclusions from Schofbeck’s letter are “complete nonsense.”